These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7136000)

  • 61. N-acetylation polymorphism of dapsone in a Japanese population.
    Horai Y; Ishizaki T
    Br J Clin Pharmacol; 1988 Apr; 25(4):487-94. PubMed ID: 3382590
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators.
    Olson W; Miceli J; Weber W
    Clin Pharmacol Ther; 1978 Feb; 23(2):204-11. PubMed ID: 620482
    [TBL] [Abstract][Full Text] [Related]  

  • 63. N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndrome.
    Siegmund W; Fengler JD; Franke G; Zschiesche M; Eike O; Eike E; Meisel P; Wulkow R
    Br J Clin Pharmacol; 1991 Oct; 32(4):467-72. PubMed ID: 1958441
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacogenetics and drug metabolism: an Irish perspective.
    Holland P; Barry M; Feely J
    Ir J Med Sci; 1991 Feb; 160(2):54-6. PubMed ID: 1917424
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oral hygiene, dietary pattern and smoking habits of Bedouin (nomadic Arabs) population in Saudi Arabia.
    Almas K; al-Amri M; al-Eid A; al-Shahrani S
    Odontostomatol Trop; 2003 Sep; 26(103):19-23. PubMed ID: 14705374
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
    [TBL] [Abstract][Full Text] [Related]  

  • 67. N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances.
    Gawrońska-Szklarz B; Górnik W; Pawlik A; Kunicki P; Wójcicki J; Sitkiewicz D; Sych Z
    Eur J Clin Pharmacol; 1997; 51(6):431-5. PubMed ID: 9112055
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clonazepam acetylation in fast and slow acetylators.
    Miller ME; Garland WA; Min BH; Ludwick BT; Ballard RH; Levy RH
    Clin Pharmacol Ther; 1981 Sep; 30(3):343-7. PubMed ID: 7273597
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Occurrence of the fast acetylation phenotype in persons with the radicular syndrome. Preliminary report].
    Milejski P; Orzechowska-Juzwenko K; Tota B; Krzysztoń Z
    Neurol Neurochir Pol; 1987; 21(6):511-5. PubMed ID: 3449771
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of urbanization on the distribution of cord serum lipids in Riyadh, Saudi Arabia: a pilot study.
    al-Nuaim AR; Bamgboye EA
    Ann Trop Paediatr; 1996 Mar; 16(1):69-74. PubMed ID: 8787369
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease].
    Milejski P; Orzechowska-Juzwenko K; Kamienowski J; Horoch E; Niewiński P; Hurkacz M; Rzemisławska Z
    Neurol Neurochir Pol; 1999; 33(5):1015-24. PubMed ID: 10672554
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sulphadimidine acetylation status in Gujarati and Marathi population.
    Kshirsagar NA; Pohujani SM; Takle MR; Acharya VN; Satoskar RS
    J Postgrad Med; 1987 Jul; 33(3):128-33. PubMed ID: 3430399
    [No Abstract]   [Full Text] [Related]  

  • 73. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide.
    Ylitalo P; Hinkka H
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):548-53. PubMed ID: 4066079
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determination of the acetylator phenotype in a Northern Nigerian population.
    Fawcett IW; Gammon PT
    Tubercle; 1975 Sep; 56(3):199-201. PubMed ID: 1216338
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetically determined sparteine oxidation and sulfadimidine acetylation polymorphism in patients with non-occupational urinary bladder cancer.
    Orzechowska-Juzwenko K; Niewiński P; Pawlik J; Milejski P; Dembowski J; Swiebodzki L; Lorenz J
    Mater Med Pol; 1994; 26(4):145-8. PubMed ID: 7666680
    [TBL] [Abstract][Full Text] [Related]  

  • 76. N-acetylation polymorphism and diabetes mellitus among Saudi Arabians.
    el-Yazigi A; Johansen K; Raines DA; Dossing M
    J Clin Pharmacol; 1992 Oct; 32(10):905-10. PubMed ID: 1447397
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report.
    Lee EJ; Lee LK
    Br J Clin Pharmacol; 1982 Mar; 13(3):375-8. PubMed ID: 7059437
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug acetylation and expression of lupus erythematosus.
    Marsden JR; Mason GG; Coburn PR; Rawlins MD; Shuster S
    Eur J Clin Pharmacol; 1985; 28(4):387-90. PubMed ID: 4029245
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Distribution of acetylator phenotypes in the Moscow population].
    Lil'in ET; Korsunskaia MP; Meksin VA; Tarlycheva LV; Shapiro EF
    Genetika; 1983 Aug; 19(8):1378-80. PubMed ID: 6685091
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acetylation of serotonin in vitro by a human N-acetyltransferase.
    White TA; Jenne JW; Evans DA
    Biochem J; 1969 Jul; 113(4):721-5. PubMed ID: 5386195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.